Zantac was first approved in 1983 and developed by GSK, becoming the world's fastest selling medication in 1988. In 2016, Sanofi acquired the treatment in an asset swap with Boehringer Ingelheim.

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...

Popular heartburn drug Ranitidine, long under scrutiny, will continue to be available in India as the government confirmed it had no plans to ban its manufacture or sale. The government had ...

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...

For those who struggle with heartburn, ranitidine drugs like Zantac can be used for relief. However, after, high levels of a chemical previously known to have been used in rocket fuel were found ...

We’ve all heard stories about how Uncle Sam pays $436 for a claw hammer, but if President Trump and Elon Musk are looking for ...

U.S. Sen. Richard Blumenthal (D-CT) called on U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D. to take “appropriate actions to investigate and recall products with unacceptable ...

GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.

U.S. Special Counsel Jack Smith concluded that Donald Trump engaged in an "unprecedented criminal effort" to hold on to power after losing the 2020 election, but was thwarted in bringing the case ...